CN Patent

CN105142636A — 用于治疗阴道感染的利福昔明

Assigned to Alfa Wasserman SpA · Expires 2015-12-09 · 10y expired

What this patent protects

本发明涉及用于治疗细菌性阴道感染的利福昔明。本发明还涉及治疗以存在细菌为特征的感染的用途，所述细菌可以是对克林霉素和/或甲硝唑有抗性的。本发明还涉及利福昔明用于治疗具有阴道感染的患者的用途，所述患者在先前的治疗后已经复发或者具有对利福昔明之外的抗生素有抗性的细菌。

USPTO Abstract

本发明涉及用于治疗细菌性阴道感染的利福昔明。本发明还涉及治疗以存在细菌为特征的感染的用途，所述细菌可以是对克林霉素和/或甲硝唑有抗性的。本发明还涉及利福昔明用于治疗具有阴道感染的患者的用途，所述患者在先前的治疗后已经复发或者具有对利福昔明之外的抗生素有抗性的细菌。

Drugs covered by this patent

Patent Metadata

Patent number
CN105142636A
Jurisdiction
CN
Classification
—
Expires
2015-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Alfa Wasserman SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.